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Thioredoxin, a ubiquitous enzyme possessing an oxidoreductase activity, has recently been cloned in human. Using in 
situ chromosomal hybridization with a human thioredoxin cDNA probe, we have precisely localized the thioredoxin gene 
on chromosome 3 at bands 3pl l-p12. 
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1. INTRODUCTION 
Thioredoxin is the best representative enzyme of 
a group of proteins, widely distributed and possess- 
ing a dithiol-disulfide oxidoreductase activity [1,2]. 
This protein of 12 000 Da is ubiquitous and found 
in many organisms, from plants and bacteria to 
mammalians. It has been identified originally in 
Escherichia coli as a hydrogen donor for 
ribonucleotide r ductase and deoxyribonucleotide 
synthesis [1]. In higher organisms, the thioredoxin 
system (which includes NADPH as a proton 
donor, thioredoxin reductase and thioredoxin) 
seems to participate as a general dithiol-disulfide 
oxidoreductase in the cells. Multiple substrates for 
thioredoxin have been identified so far, such as 
ribonuclease [3], glucocorticoid receptor [4], and 
insulin [5]. Recently, a factor called acute T 
leukemia derived factor (ADF), almost identical to 
human thioredoxin, has been described [6]. It has 
been reported that ADF has an immunological 
role, such as induction of the p55 Tac interleukin-2 
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receptor subunit on a natural killer cell line called 
YT [6]. In the present study, using in situ hybri- 
dization on human prometaphase cells with a 
human thioredoxin (HTR) cDNA previously ob- 
tained in our laboratory [7], we report that that 
HTR gene is located on the short arm of 
chromosome 3 at bands pl 1-p12. 
2. MATERIALS AND METHODS 
DNA probe: cDNA clones encoding for human thioredoxin 
were isolated from the 3156 EBV lymphoblastoid B cell line [7]. 
The HTR cDNA probe used for both Northern blot analysis and 
in situ hybridization was an EcoRI-DraI 0.42 kb fragment excis- 
ed from the PGEM3-HTR recombinant plasmid established by 
E.E. Wollman (fig.la). 
Northern blot analysis was performed as described previously 
[7]. Total RNA was extracted from the 3B6 lymphoblastoid B 
cell line, transferred on a nylon filter and hybridized with the 
HTR probe. 
In situ hybridization was performed according to the pro- 
cedure described by Lafage et al. [8]. The DNA probe was 
tritium labeled to a specific activity of 2 x 107 cpm//~g and 
hybridized on normal human male prometaphase spreads at a 
final concentration of 50 ng per ml of hybridization buffer. 
Autoradiographs were exposed at 4°C for 15 days. 
3. RESULTS AND DISCUSSION 
Abbreviation: HTR, human thioredoxin In order to ensure the specificity of our HTR 
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Fig. lb: Restriction map of the HTR gene. The coding region is boxed and restriction sites are shown with their base pair assignments. 
Fig.la: Northern blot analysis of the 3B6 cell line with the HTR probe. First lane, RNA size markers ynthesized bythe SP6 RNA 
polymerase; second lane, RNA extracted from the 3B6 cell line. 
probe, we performed a Northern blot analysis on 
total RNA extracted from the 3B6 lymphoblastoid 
B cell line (fig. lb) and we detected the single HTR 
mRNA species at the 550 base level [7]. 
Results of in situ hybridization with the HTR 
cDNA probe are shown in figs 2 and 3. 58 pro- 
metaphase cells were analyzed for silver grains 
associated with chromosomes. A total of 122 silver 
grains was scored (i.e., an average of 2.1 grains per 
cell), and 25 grains (20.5070 of the total grains) were 
found to be associated with chromosome 3 (X 2, 
p < 10-8) [9]. Of  the 25 silver grains associated with 
chromosome 3, 18 grains (72070) mapped to region 
3pl, the proximal region of the short arm of 
chromosome 3. More precisely, the maximal 
number of silver grains was observed at the 
3pl 1-p12 bands (figs 3 and 4). There were no other 
highly significant clusters of silver grains in the 
other chromosomal regions (fig. 2). Consequently, 
we assigned the human thioredoxin gene to 
chromosome 3 at bands pl 1-p12. 
Several genes have been mapped in a 
chromosomal region encompassing bands 
3pl 1-p12 [10] such as the ~'l-galactosidase gene at 
region 3p21-cen [ 11,12], the glutathione peroxidase 
1 gene at region 3p13-q12 [11,13], and the protein 
KI. 
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Fig.2. Distr ibut ion of silver grains scored over all chromosomes in 58 prometaphases after in situ hybr id izat ion with the HTR probe. 
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Fig.3. Diagram of G-banded chromosome 3 showing the detail- 
ed distribution of labeled sites. 
S gene at region 3p11.1-q11.2 [14]. But so far, the 
HTR gene is the most precise gene marker of the 
3pl l-p12 region. 
Moreover, chromosomal clonal abnormalities 
involving this region have been described [15] in 
some breast cancers [16-19] and in some cutaneous 
T cell lymphomas [20,21]. Whether the HTR gene 
is involved in these malignancies remains to be in- 
vestigated. 
Fig.4. Partial representative prometaphase howing the specific 
location of the HTR gene on chromosome 3. Arrowheads in- 
dicate silver grains. Left, Giemsa staining; right, subsequent R- 
banding. 
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